Multicenter Studies

Pharmahungary Group is offering a unique service in preclinical development, i.e. small and large animal multicenter studies for myocardial infarction and heart failure. The know-how and network of the sites were developed in a COST (EU-CARDIOPROTECTION, CA16225) and COST Innovators Grant (IMPACT, IG16225) led by Semmelweis University and University College London. Pharmahungary, the SME partner will utilize the know-how of preclinical multicenter trials according to the agreement with the consortium.


See selected references:

  • Sayour NV et al, Cardiovasc Res, 2023 (PMID: 36718529)